NCT04421053|Unknown
Weight Gain Recommendations for Chinese Women With Gestational Diabetes Mellitus
Gestational Weight Gain (GWG) Recommendations for Chinese Women With Gestational Diabetes Mellitus (GDM)
Loading search results
Gestational Weight Gain (GWG) Recommendations for Chinese Women With Gestational Diabetes Mellitus (GDM)
Sponsor study identifier
observational
4,050
1 country
1
Study Start
March 24, 2020
Actual (reported)Primary Completion
December 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 30, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The 2009 IOM recommendation value for weight gain during pregnancy is widely used. Due to the unclear relationship between gestational diabetes mellitus and weight gain during pregnancy when formulating this recommendation value, pregnant women with gestational diabetes mellitus were excluded from the study population. Control of appropriate weight gain and control of blood glucose stability is an important part of GDM management in pregnant women. The incidence of GDM in China is about 15%-20%, and the number of pregnant women with GDM ranks first in the world. For the sake of the current and long-term health of maternal and infant, it is of great significance to explore the appropriate weight gain range and formulate the recommended value for GDM pregnant women as an independent population. This project intends to use prospective cohort study of combining the observation of pregnant women with gestational diabetes blood sugar and weight changes, through the comparison of normal pregnant women suitable scope of weight gain, analyzes its influence on adverse pregnancy outcomes, increased the weight of gestational diabetes women recommended value is put forward, and combined with the Delphi expert consultation method for evaluation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 30, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 24, 2020
Actual (reported)June 5, 2020
Actual (reported)June 9, 2020
Actual (reported)December 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 30, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The incidence rate of pregnancy outcomes
pregnancy outcomes including preeclampsia, gestational hypertension.
delivery
The incidence rate of infant outcomes
infant outcomes including SGA,neonatal hypoglycemia.
delivery
the value of gestational weight gain during third trimester
from enrollment to delivery
After participants enrollment, we conducted follow-up visit every two weeks. Blood glucose values, body weight, life style record and clinical information are collected. Blood samples and stool samples are collected from participants in Beijing.
we conduct prenatal care for GDM pregnancies through both prenatal clinic and app.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
pregnancies with gestational diabetes mellitus
Department of ob gyn, Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
blood samples and stool samples are collected from participants in Beijing.
Liangkun Ma
Chinese Academy of Medical Science & Peking Union Medical College Hospital
First Submitted
June 5, 2020
First Posted
June 9, 2020
Study Start
March 24, 2020
Actual (reported)Primary Completion
December 30, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes Mellitus
Contact the study team to confirm eligibility.
Study Completion
June 30, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
October 21, 2021
Record last verified: 2021-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: